2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide

C14H22N4O — CID 79607356

IUPAC2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide
SMILESO=C(CC1CC2CCC(C1)N2)NCCn1cccn1
InChIInChI=1S/C14H22N4O/c19-14(15-5-7-18-6-1-4-16-18)10-11-8-12-2-3-13(9-11)17-12/h1,4,6,11-13,17H,2-3,5,7-10H2,(H,15,19)
InChIKeyRIWMWTCINVRVCG-UHFFFAOYSA-N
MW262.36 g/mol
LogP0.92
Rot. Bonds5

About 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide

2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide (PubChem CID 79607356) has the molecular formula C14H22N4O and a molecular weight of 262.36 g/mol. Its IUPAC name is 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide.

Molecular Properties

Compound Name2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide
PubChem CID79607356
Molecular FormulaC14H22N4O
Molecular Weight262.36 g/mol
Exact Mass262.18
IUPAC Name2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide
SMILESO=C(CC1CC2CCC(C1)N2)NCCn1cccn1
InChIInChI=1S/C14H22N4O/c19-14(15-5-7-18-6-1-4-16-18)10-11-8-12-2-3-13(9-11)17-12/h1,4,6,11-13,17H,2-3,5,7-10H2,(H,15,19)
InChIKeyRIWMWTCINVRVCG-UHFFFAOYSA-N
XLogP0.92
TPSA58.95 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500262.36
LogP ≤ 50.92
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[[3-(pyrazol-1-ylmethyl)phenyl]methyl]acetamide
CID 119744704
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-(azepan-1-yl)ethyl]acetamide
CID 79610567
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[(2-pyrazol-1-ylphenyl)methyl]acetamide;hydrochloride
CID 119739831
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyridin-2-ylethyl)acetamide
CID 79608018
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-[4-(dimethylamino)piperidin-1-yl]ethyl]acetamide
CID 119895441
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[3-(pyridin-2-ylamino)propyl]acetamide;dihydrochloride
CID 119854577
3-[[2-(8-azabicyclo[3.2.1]octan-3-yl)acetyl]amino]propanamide
CID 79607251
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[2-[ethyl(propyl)amino]ethyl]acetamide
CID 103814955
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(3-oxo-3-pyrrolidin-1-ylpropyl)acetamide
CID 79610570
4-oxo-4-(2-pyrazol-1-ylethylamino)butanoic acid
CID 61460027
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride
CID 119710712
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-methylsulfinylethyl)acetamide
CID 115739227

Frequently Asked Questions

What is the IUPAC name of 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide?
The IUPAC name of 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide (CID 79607356) is 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide.
What is the SMILES notation for 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide?
The canonical SMILES for 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide is O=C(CC1CC2CCC(C1)N2)NCCn1cccn1.
What is the InChIKey of 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide?
The InChIKey is RIWMWTCINVRVCG-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H22N4O/c19-14(15-5-7-18-6-1-4-16-18)10-11-8-12-2-3-13(9-11)17-12/h1,4,6,11-13,17H,2-3,5,7-10H2,(H,15,19).
What are the key properties of 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide?
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide has a molecular weight of 262.36 g/mol, XLogP of 0.92, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-(2-pyrazol-1-ylethyl)acetamide is sourced from PubChem (CID 79607356), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).